focus -WSS

focus

author：hotspot 2025-08-11 11:42:24 - browse：51535

Is there a cure for allergies? Has the FDA become too flexible? And which drugs make you muscular?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recorded live from from the STAT Breakthrough Summit East in New York City, we discuss some event highlights, including words from CRISPR pioneer Feng Zhang and Regeneron Pharmaceuticals head scientist George Yancopoulos. We also discuss the latest news in the life sciences, including a twist in the GLP-1 story, the cost of gene therapy, and, of course, pie.

For more on what we cover, here’s our full Summit coverage; here’s more on Medicare and GLP-1s; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： AdventHealth escalates lawsuit against insurance vendor Multiplan

WSS

JPM: CVS says Medicare Advantage patients are impacting profits

Antibiotic resistance and the global rise in human conflict

Ahead of JPM, here's who's profiting most in health care

Oprah kicked off a national conversation on obesity. Let's have it

Roche subsidiary Foundation Medicine opens new headquarters

Vertex Pharmaceuticals may move headquarters in Boston

explore

focus

leisure time

Malaria cases in Florida and Texas: Here’s what you need to know

Feng Zhang CRISPR delivery startup lays off quarter of staff

How to save PrEP access — and even expand it

Primary care physicians play key roles in Alzheimer's management

Drug repurposing or repositioning? The language matters

Why the world’s most expensive drug might be worth the price

The cancer drug shortage isn’t new — and neither are the solutions

Why the world’s most expensive drug might be worth the price

Hollywood unions extend contract negotiations for actors

Videos point to link between seizures and unexplained toddler deaths

knowledge

Feng Zhang CRISPR delivery startup lays off quarter of staff

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Readout LOUD podcast: mifepristone case, GLP

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Washington mulls new rules to avert another Change Healthcare

knowledge

leisure time

focus

focus